van Leeuwen EF - Search Results

1

A new low-incidence antigen in the Kell blood group system: VLAN (KEL25).

Jongerius JM, Daniels GL, Overbeeke MA, Petty AC, Reid M, Oyen R, Rijksen H, van Leeuwen EF. Jongerius JM, et al. Vox Sang. 1996;71(1):43-7. doi: 10.1046/j.1423-0410.1996.7110043.x. Vox Sang. 1996. PMID: 8837356

2

A simple strategy to look back on posttransfusion hepatitis B in a multitransfused patient.

Jongerius JM, van der Poel CL, van Leeuwen EF. Jongerius JM, et al. Vox Sang. 1998;75(1):66-9. Vox Sang. 1998. PMID: 9745157

3

New hepatitis B virus mutant form in a blood donor that is undetectable in several hepatitis B surface antigen screening assays.

Jongerius JM, Wester M, Cuypers HT, van Oostendorp WR, Lelie PN, van der Poel CL, van Leeuwen EF. Jongerius JM, et al. Transfusion. 1998 Jan;38(1):56-9. doi: 10.1046/j.1537-2995.1998.38198141499.x. Transfusion. 1998. PMID: 9482395

4

Maternal antibodies against fetal blood group antigens A or B: lytic activity of IgG subclasses in monocyte-driven cytotoxicity and correlation with ABO haemolytic disease of the newborn.

Brouwers HA, Overbeeke MA, Ouwehand WH, Keuning K, van Ertbruggen I, van Leeuwen EF, Stoop JW, Engelfriet CP. Brouwers HA, et al. Br J Haematol. 1988 Dec;70(4):465-9. doi: 10.1111/j.1365-2141.1988.tb02518.x. Br J Haematol. 1988. PMID: 3219297

5

Human immunodeficiency virus (HIV) antibodies detected by new assays that are enhanced for HIV-1 subtype O.

Jongerius JM, van der Poel CL, van Loon AM, van den Akker R, Schaasberg W, van Leeuwen EF. Jongerius JM, et al. Transfusion. 1997 Aug;37(8):841-4. doi: 10.1046/j.1537-2995.1997.37897424408.x. Transfusion. 1997. PMID: 9280330

6

What is the best predictor of the severity of ABO-haemolytic disease of the newborn?

Brouwers HA, Overbeeke MA, van Ertbruggen I, Schaasberg W, Alsbach GP, van der Heiden C, van Leeuwen EF, Stoop JW, Engelfriet CP. Brouwers HA, et al. Lancet. 1988 Sep 17;2(8612):641-4. doi: 10.1016/s0140-6736(88)90466-7. Lancet. 1988. PMID: 2901516

7

Evaluation of automated nucleic acid extraction devices for application in HCV NAT.

Jongerius JM, Bovenhorst M, van der Poel CL, van Hilten JA, Kroes AC, van der Does JA, van Leeuwen EF, Schuurman R. Jongerius JM, et al. Transfusion. 2000 Jul;40(7):871-4. doi: 10.1046/j.1537-2995.2000.40070871.x. Transfusion. 2000. PMID: 10924618

8

Sensitive methods for determining subclasses of IgG anti-A and anti-B in sera of blood-group-O women with a blood-group-A or -B child.

Brouwers HA, Overbeeke MA, Gemke RJ, Maas CJ, van Leeuwen EF, Engelfriet CP. Brouwers HA, et al. Br J Haematol. 1987 Jun;66(2):267-70. doi: 10.1111/j.1365-2141.1987.tb01310.x. Br J Haematol. 1987. PMID: 3300763

9

Blood transfusion in premature or young infants with polyagglutination and activation of the T antigen.

Engelfriet CP, Reesink HW, Strauss RG, Luban NL, Letsky E, Modi N, Zupańska B, van Leeuwen EF, Martín-Vega C, Krusius T. Engelfriet CP, et al. Vox Sang. 1999;76(2):128-32. Vox Sang. 1999. PMID: 10232999 No abstract available.

10

Effect of the binding of anti-Zwa antibodies on platelet function.

van Leeuwen EF, Leeksma OC, van Mourik JA, Engelfriet CP, von dem Borne AE. van Leeuwen EF, et al. Vox Sang. 1984;47(4):280-9. doi: 10.1111/j.1423-0410.1984.tb01599.x. Vox Sang. 1984. PMID: 6548327

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

131 results

Search Page

Filters